AstraZeneca has announced a $2.5 billion investment in a research and development hub in Beijing, underscoring its commitment to China, its...

Sanofi is one of the world's top producers of insulin, and the China market for treatment of the illness is huge: Some 140 million people i...

Vice President Han Zheng emphasizes innovation in advanced sectors and market-oriented, law-based environment to attract foreign firms, ens...

The cash deal, which adds several experimental therapies to AstraZeneca's portfolio, values Gracell at $2 per ordinary share, or $10 per AD...

Soriot was tasked with turning around a troubled AstraZeneca - hit by a string of key patent losses and a spate of clinical trial failures ...

The Anglo-Swedish company's third-quarter results showed the vaccine contributed one cent to core earnings per share of $1.08, a rise of 14...

"Delta cases surge in US & Israel shows mRNA vaccines need a heterogeneous booster to strengthen & prolong immune response. #SputnikV pione...

In a barrage of editorials, political cartoons and social-media posts in recent days, the Communist Party-backed Global Times newspaper bla...

"Sputnik has received EUA (emergency use authorisation)," the minister, Faisal Sultan, told Reuters in a WhatsApp text message.

HEALTH-CORONAVIRUS-INDIA-Vaccine diplomacy: India seeks to rival China with broad shipments

India for years has struggled to match the pace of Chinese investment in countries such as Sri Lanka, Nepal and the Maldives, where China i...

COVAX, a global scheme co-led by the WHO, wants to deliver at least 2 billion COVID-19 doses across the world this year, with at least 1.3 ...

In the 50-share pack Nifty, M&M was the biggest gainer, up 2.05 per cent. UPL, TCS, HDFC, SBI, Tata Motors, Shree Cement, ITC, Infosys and ...

Alexion shareholders will receive $60 in cash and 2.1243 AstraZeneca American Depositary Shares per Alexion share.

Analysts said while Nifty’s bias remains negative, Thursday’s weekly derivatives expiry may lead to a short-covering bounce.

The NSE Nifty50 index was down 17 points at 10,804, while the BSE Sensex was 70 points down at 35,620 around 11:55 am.

Anglo-Swedish pharmaceuticals giant AstraZeneca said that it would slash 1,400 jobs by 2013 as it shuts factories in Belgium, Spain and Swe...